Gene patent ruling could improve access, patient care

06/13/2013 | CBS News · Medscape (free registration) · HealthDay News

The Supreme Court's decision Thursday to prohibit the patenting of human genes could improve patient care, boost access to genetic testing and cut costs, supporters say. The cost of gene testing will fall and access to second opinions will increase, according to the American Society for Clinical Pathology, one of the plaintiffs in the case. "Because of this ruling, patients will have greater access to genetic testing and scientists can engage in research on these genes without fear of being sued," said Dr. Myra F. Barginear, a New York oncologist.

View Full Article in:

CBS News · Medscape (free registration) · HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health